Teva Pharmaceuticals USA recalls Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis
Teva Pharmaceuticals USA recalls 50mg Metoprolol Succinate Extended Release Tablets due to failed dissolution test. No remedy specified in official notice.
Recall notice
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Contact the company & request your remedy
What happened, in plain English
Teva Pharmaceuticals USA is recalling 50mg Metoprolol Succ: Extended Release Tablets (100-count bottles) because they failed dissolution tests during routine quality checks. This could mean the medication doesn't work properly when taken as intended. Read more at govinfonow.com/recall/39486-teva-metoprolol-succinate-tablets-recall-failed-dissolution-test.
Source Summary by GovInfoNow · govinfonow.com/recall/39486-teva-metoprolol-succinate-tablets-recall-failed-dissolution-test · Updated October 5, 2026 · FDA enforcement record: FDA #D-0129-2019
Cite this page
“Teva Metoprolol Succinate Tablets Recall: Failed Dissolution Test.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39486-teva-metoprolol-succinate-tablets-recall-failed-dissolution-test. Based on FDA recall #D-0129-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0129-2019%22&limit=1).
Why it’s dangerous
The medication failed dissolution tests during routine quality checks. This means the tablets might not release the active ingredient properly when taken, potentially causing ineffective treatment.
Who’s affected
People with prescriptions for this medication who bought it from pharmacies or hospitals. Those with heart conditions requiring this drug are most at risk.
How to tell if you have this one
Check for the 50mg Metoprolol Succinate Extended Release Tablets, 100-count bottle, manufactured by Actavis Laboratories FL, Inc. in Fort Lauderdale, FL. The lot number is 1220211M with an expiration date of 02/2019.
- Brand
Teva Pharmaceuticals USA- Category
Drug
What to do — step by step
Check Product Details
Look for the 50mg Metoprolol Succinate Extended Release Tablets, 100-count bottle, manufactured by Actavis Laboratories FL, Inc. in Fort Lauderdale, FL with lot number 1220211M.
Questions people ask
Is this medication dangerous?
The recall is due to failed dissolution tests, which could mean the medication doesn't work properly. However, the official notice does not specify if this causes serious harm.
What should I do with the recalled product?
The official recall notice does not specify a remedy or action for the product.
How can I tell if I have the recalled product?
Check for the 50mg Metoprolol Succinate Extended Release Tablets, 100-count bottle, manufactured by Actavis Laboratories FL, Inc. in Fort Lauderdale, FL with lot number 1220211M.
Contact Teva Pharmaceuticals USA
We’ve drafted a message you can send Teva Pharmaceuticals USA to request your refund or repair — edit it as you like.
Subject: Recall D-0129-2019 — Teva Pharmaceuticals USA Teva Pharmaceuticals USA Hello, I own a Teva Pharmaceuticals USA that is covered by recall D-0129-2019 from Teva Pharmaceuticals USA. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0129-2019 (October 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0129-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.